BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 32412717)

  • 1. Clinical, Histologic, and Molecular Characteristics of Anaplastic Lymphoma Kinase-positive Primary Cutaneous Anaplastic Large Cell Lymphoma.
    Melchers RC; Willemze R; van de Loo M; van Doorn R; Jansen PM; Cleven AHG; Solleveld N; Bekkenk MW; van Kester MS; Diercks GFH; Vermeer MH; Quint KD
    Am J Surg Pathol; 2020 Jun; 44(6):776-781. PubMed ID: 32412717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Screening in Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma: Anaplastic Lymphoma Kinase Analysis, Next-Generation Sequencing Fusion Gene Detection, and T-Cell Receptor Immunoprofiling.
    Kalinova M; Mrhalova M; Kabickova E; Svaton M; Skotnicova A; Prouzova Z; Krenova Z; Kolenova A; Divoka M; Fronkova E; Kodet R
    Mod Pathol; 2024 Mar; 37(3):100428. PubMed ID: 38266918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis and therapeutic targeting of the IL-1R pathway in anaplastic large cell lymphoma.
    Song Z; Wu W; Wei W; Xiao W; Lei M; Cai KQ; Huang DW; Jeong S; Zhang JP; Wang H; Kadin ME; Waldmann TA; Staudt LM; Nakagawa M; Yang Y
    Blood; 2023 Oct; 142(15):1297-1311. PubMed ID: 37339580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary cutaneous anaplastic large-cell lymphoma resembling infratemporal space infection: a case report.
    Yan X; Ren W; Li S; Zhu Z; Gao L; Zhi K
    BMC Oral Health; 2024 Apr; 24(1):470. PubMed ID: 38637781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cutaneous ALK rearranged spindle cell neoplasm and S-100/CD34 co-expression: report of a case].
    Zhang W; Wang Y; Wang H; Gao Y; Chen YL
    Zhonghua Bing Li Xue Za Zhi; 2024 May; 53(5):498-500. PubMed ID: 38678336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anaplastic large cell lymphoma with ALK::ATIC fusion mimicking a histiocytic sarcoma debuting as an anterior thoracic soft tissue tumor with exceptional clinicopathological, morphological and molecular features.
    García-Muñiz JA; Vilches-Cisneros N; Flores-Gutiérrez JP; Barboza-Quintana O
    Thorac Cancer; 2024 May; 15(13):1103-1105. PubMed ID: 38523398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anaplastic Large Cell Lymphoma of the Spine: Report of a Rare Case.
    Ali Y; Naeem UH; Rahman HU; Khan S; Amin S; Ahmad K; Durrani H
    Cureus; 2024 Feb; 16(2):e54602. PubMed ID: 38524078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dramatic progression of multifocal primary cutaneous anaplastic large-cell lymphoma.
    Avallone G; Leo F; Astrua C; Mastorino L; Parente R; Grassi M; Fabrizio R; Ferraris A; Quaglino P; Ribero S
    Ital J Dermatol Venerol; 2024 Apr; 159(2):215-216. PubMed ID: 38436616
    [No Abstract]   [Full Text] [Related]  

  • 9. Unusual clinical presentation of anaplastic large cell lymphoma.
    de Campos FPF; Zerbini MCN; Felipe-Silva A; Simões AB; Lovisolo SM; da Fonseca LG; Laborda L
    Autops Case Rep; 2014; 4(1):21-27. PubMed ID: 28652989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New Advances in Liquid Biopsy Technologies for Anaplastic Lymphoma Kinase (ALK)-Positive Cancer.
    Villa M; Sharma GG; Manfroni C; Cortinovis D; Mologni L
    Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anaplastic Large Cell Lymphoma (ALCL) With a Sarcomatoid Variant Presenting As Distributive Shock in a 41-Year-Old Female: A Case Report.
    Alhusari L; Abdallah M; Dakkak B; Bsiso T; Jamil M
    Cureus; 2024 Feb; 16(2):e55235. PubMed ID: 38558574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anaplastic lymphoma kinase-positive pulmonary inflammatory myofibroblastic tumour: a case report.
    Tong D; Chisholm J; Madden B; Ahmed M
    J Med Case Rep; 2024 Apr; 18(1):167. PubMed ID: 38594735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic ALK-positive anaplastic large cell lymphoma with bilateral optic neurolymphomatosis resulting in permanent blindness.
    Seegobin K; Alhaj Moustafa M; Fischer D; Keller K; Hastings J; Kharfan-Dabaja MA; Ayala E; Gupta V; Tun HW; Jiang L
    Clin Case Rep; 2020 Dec; 8(12):2629-2633. PubMed ID: 33363793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kemps PG, Picarsic J, Durham BH, et al. ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition. Blood. 2022;139(2):256-280.
    Blood; 2023 Jun; 141(22):2785-2786. PubMed ID: 37261851
    [No Abstract]   [Full Text] [Related]  

  • 15. An update in management of noncutaneous T-cell lymphomas.
    Hwang YY; Liang RH
    Adv Hematol; 2010; 2010():424786. PubMed ID: 21188274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Composite ALK-negative anaplastic large cell lymphoma and follicular lymphoma involving jejunum and mesenteric lymph nodes.
    Yang Q; Zhang T; Fang N; Sun W
    Pathol Int; 2024 Apr; ():. PubMed ID: 38656535
    [No Abstract]   [Full Text] [Related]  

  • 17. Mycosis Fungoides and Sézary Syndrome: An Integrative Review of the Pathophysiology, Molecular Drivers, and Targeted Therapy.
    García-Díaz N; Piris MÁ; Ortiz-Romero PL; Vaqué JP
    Cancers (Basel); 2021 Apr; 13(8):. PubMed ID: 33923722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated genomic analyses of cutaneous T-cell lymphomas reveal the molecular bases for disease heterogeneity.
    Park J; Daniels J; Wartewig T; Ringbloom KG; Martinez-Escala ME; Choi S; Thomas JJ; Doukas PG; Yang J; Snowden C; Law C; Lee Y; Lee K; Zhang Y; Conran C; Tegtmeyer K; Mo SH; Pease DR; Jothishankar B; Kwok PY; Abdulla FR; Pro B; Louissaint A; Boggon TJ; Sosman J; Guitart J; Rao D; Ruland J; Choi J
    Blood; 2021 Oct; 138(14):1225-1236. PubMed ID: 34115827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenges in utilizing ALK expression to distinguish primary cutaneous from systemic anaplastic large cell lymphoma.
    Gleason L; Afifi L; Banner L; Talasila S; Joffe D; Bhatti S; Alpdogan O; Porcu P; Nikbakht N
    Mol Clin Oncol; 2024 May; 20(5):35. PubMed ID: 38596625
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.